EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search
  • company-list.svg
    My Watchlists (Beta)

TuHURA Biosciences

Overview
News
CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics. It has developed proprietary mitochondria based therapeutic (MBT) platform technology, using cell-based assays and animal models of disease, to rapidly identify naturally occurring MDPs with promising biological activity. The company was founded in 2007 and is headquartered in Menlo Park, California.
HQ location:
Menlo Park, CA
Founded year:
2007
Employees:
1-10
IPO status:
Public
Total funding:
USD 39.6 mn
Last Funding:
USD 15.0 mn (Post IPO Equity; Oct 2021)
Last valuation:
-
Funding data are powered by Crunchbase
About EDGE
Contact Us
Resources
EDGE

Technology Research Made Effortless

Get a demo
Terms & conditionsPrivacy policyDo not sell my personal information
SPEEDA Edge is owned by Uzabase, the business intelligence and media company. ©2024 Uzabase, Inc. and Uzabase USA, Inc. All rights reserved.
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.